Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)

BACKGROUND: Aspirin is a key antiplatelet therapy for the prevention of thrombotic events in patients with cardiovascular disease. Studies suggest that ≈20% of patients with cardiac disease suffer from aspirin nonsensitivity, a phenomenon characterized by the inability of 81 mg aspirin to inhibit pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Hamzah, Zamzam, Abdelrahman, Gallant, Reid C., Syed, Muzammil H., Rand, Margaret L., Ni, Heyu, Forbes, Thomas L., Al‐Omran, Mohammed, Qadura, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595963/
https://www.ncbi.nlm.nih.gov/pubmed/34816074
http://dx.doi.org/10.1002/rth2.12618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595963/
https://www.ncbi.nlm.nih.gov/pubmed/34816074
http://dx.doi.org/10.1002/rth2.12618

Ejemplares similares